腹部大手术后综合并发症指数的最小重要差值:超越P值
本研究基于3项随机对照试验和1项前瞻性观察研究(n=1583)的个体患者数据,采用锚定法估算腹部大手术患者综合并发症指数(CCI®)的最小重要差值(MID)。结直肠外科中多个患者报告结局指标与CCI®相关性≥|0.30|,MID估计范围为6.1至22.2;肝胆胰外科中MID范围为6.2至13.8。最终提出组间CCI®平均差异12分作为腹部手术患者的临床相关差异。
要点
- 腹部大手术后CCI®的MID为12分,可用于样本量计算和试验解读。
- MID基于患者报告结局锚定法,结直肠与肝胆胰外科估计值有所重叠。
- 统计学显著差异不一定具有临床相关性,需结合MID判断。
核心结论
- 提出腹部大手术患者组间CCI®平均差异12分作为临床相关差异。
研究设计与样本
- 从3项已发表随机对照试验和1项前瞻性观察研究提取个体患者数据,共1583例腹部大手术患者。
- 使用锚定法,仅当患者报告结局指标评分变化与CCI®的Spearman相关系数≥|0.30|时才作为锚。
- 采用线性回归估算不同锚下的CCI® MID,并通过三角验证确定单一MID。
主要发现
- 结直肠外科队列中,Short Form-36的2个亚评分、Multidimensional Fatigue Inventory-20的2个亚评分、EuroQol-5-Dimension指数评分和EuroQol视觉模拟量表与CCI®相关性≥|0.30|。
- 结直肠外科中CCI®的MID估计范围为6.1至22.2。
- 肝胆胰外科中,Short Form-36的1个亚评分和Patient Reported Outcome Measure Information System-29问卷的2个亚评分符合锚定标准,MID估计范围为6.2至13.8。
关键数值与推荐
- 锚定标准:患者报告结局指标评分变化与CCI®的Spearman相关系数≥|0.30|。
- 最终推荐:组间CCI®平均差异12分作为腹部手术患者的临床相关差异。
临床怎么用
- 在腹部大手术随机对照试验和大型真实世界观察研究中,可用CCI®的MID 12分进行样本量计算和结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the minimal important difference (MID) of the Comprehensive Complication Index (CCI ® ) in patients undergoing abdominal surgery. BACKGROUND: The CCI ® is a validated metric that quantifies cumulative surgical morbidity. While the CCI ® is a sensitive endpoint to detect treatment effects, a statistically significant effect does not necessarily translate into clinical relevance. Relevant differences from the patients' perspective are best captured by the MID. METHODS: Individual patient data were extracted from surgical studies reporting CCI ® at 30 days and using patient-reported outcome measures with established MIDs at baseline and 30 days. To determine the MID for the CCI ® , we used an anchor-based approach as recommended by methods guidelines. A patient-reported outcome measure was selected as an anchor only if the Spearman correlation coefficient between its change in score (baseline to 30 days postoperative) and the CCI ® was ≥|0.30|. We used linear regression to estimate the MID of the CCI ® across different anchors, and triangulation to determine a single MID. RESULTS: Data were extracted from 3 published randomized controlled trials and 1 prospective observational study (n = 1583 patients) in major abdominal surgery. In colorectal surgery cohorts, 2 subscores of the Short Form-36, 2 subscores of the Multidimensional Fatigue Inventory-20, the EuroQol-5-Dimension Index Score, and the EuroQol Visual Analog Scale showed a correlation with the CCI ® of ≥|0.30|. This resulted in MID estimates for the CCI ® ranging from 6.1 to 22.2. In hepato-pancreato-biliary surgery, 1 subscore of the Short Form-36, and 2 subscores of the Patient Reported Outcome Measure Information System-29 questionnaire qualified as anchors providing MID estimates ranging from 6.2 to 13.8. CONCLUSIONS: We propose a mean difference of 12 points in the CCI ® between treatment groups as a relevant difference in patients undergoing abdominal surgery. This MID provides an important foundation for sample size calculations and interpretation of randomized controlled trials and large real-world observational studies.
引用
- Abbassi F, Pfister M, Braun J, et al. Beyond P Values : Novel Minimal Important Difference of the Comprehensive Complication Index That Reflects a Meaningful Outcome for Patients Undergoing Major Abdominal Surgery. Ann Surg. 2025. PMID: 40793921. doi:10.1097/SLA.0000000000006877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。